Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Canberk, P. Guneş, Mine Onenerk, Murat Erkan, E. Kılınç, Nilufer Gursan, G. Kilicoglu (2016)
New Concept of the Encapsulated Follicular Variant of Papillary Thyroid Carcinoma and Its Impact on the Bethesda System for Reporting Thyroid Cytopathology: A Single-Institute ExperienceActa Cytologica, 60
K. Strickland, B. Howitt, E. Marqusee, E. Alexander, E. Cibas, J. Krane, J. Barletta (2015)
The Impact of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma on Rates of Malignancy for Fine-Needle Aspiration Diagnostic Categories.Thyroid : official journal of the American Thyroid Association, 25 9
R. Lloyd, L. Erickson, M. Casey, King Lam, C. Lohse, S. Asa, J. Chan, R. DeLellis, H. Harach, K. Kakudo, V. Livolsi, J. Rosai, T. Sebo, M. Sobrinho-Simões, B. Wenig, M. Laé (2004)
Observer Variation in the Diagnosis of Follicular Variant of Papillary Thyroid CarcinomaThe American Journal of Surgical Pathology, 28
M. Rivera, J. Ricarte-Filho, R. Tuttle, I. Ganly, A. Shaha, J. Knauf, J. Fagin, R. Ghossein (2010)
Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension.Thyroid : official journal of the American Thyroid Association, 20 10
M. Rivera, R. Tuttle, S. Patel, A. Shaha, Jatin Shah, R. Ghossein (2009)
Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern).Thyroid : official journal of the American Thyroid Association, 19 2
M. Pusztaszeri, E. Rossi, M. Auger, Z. Baloch, J. Bishop, M. Bongiovanni, A. Chandra, B. Cochand‐Priollet, G. Fadda, M. Hirokawa, Soonwon Hong, K. Kakudo, J. Krane, R. Nayar, S. Parangi, F. Schmitt, W. Faquin (2016)
The Bethesda System for Reporting Thyroid Cytopathology: Proposed Modifications and Updates for the Second Edition from an International PanelActa Cytologica, 60
B. Howitt, Sue Chang, M. Eszlinger, R. Paschke, Michael Drage, J. Krane, J. Barletta (2015)
Fine-needle aspiration diagnoses of noninvasive follicular variant of papillary thyroid carcinoma.American journal of clinical pathology, 144 6
Z. Baloch, E. Cibas, D. Clark, L. Layfield, B. Ljung, M. Pitman, A. Abati (2008)
The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summationCytoJournal, 5
P. Straccia, E. Rossi, T. Bizzarro, C. Brunelli, F. Cianfrini, D. Damiani, G. Fadda (2015)
A meta‐analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?Cancer Cytopathology, 123
Z. Baloch, R. Seethala, W. Faquin, M. Papotti, F. Basolo, G. Fadda, G. Randolph, S. Hodak, Y. Nikiforov, S. Mandel (2016)
Noninvasive follicular thyroid neoplasm with papillary‐like nuclear features (NIFTP): A changing paradigm in thyroid surgical pathology and implications for thyroid cytopathologyCancer Cytopathology, 124
D. Poller, Z. Baloch, G. Fadda, S. Johnson, M. Bongiovanni, A. Pontecorvi, B. Cochand‐Priollet (2016)
Thyroid FNA: New classifications and new interpretationsCancer Cytopathology, 124
J. Higgins, S. Thompson, J. Deeks, D. Altman (2003)
Measuring inconsistency in meta-analysesBMJ : British Medical Journal, 327
Y. Nikiforov, R. Seethala, G. Tallini, Z. Baloch, F. Basolo, L. Thompson, J. Barletta, B. Wenig, A. Ghuzlan, K. Kakudo, T. Giordano, V. Alves, E. Khanafshar, S. Asa, A. El-Naggar, W. Gooding, S. Hodak, R. Lloyd, G. Maytal, O. Mete, M. Nikiforova, V. Nosé, M. Papotti, D. Poller, P. Sadow, A. Tischler, R. Tuttle, Kathryn Wall, V. Livolsi, G. Randolph, R. Ghossein (2016)
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.JAMA oncology, 2 8
W. Faquin, Lawrence Wong, A. Afrogheh, Syed Ali, J. Bishop, M. Bongiovanni, M. Pusztaszeri, C. VandenBussche, Jolanta Gourmaud, L. Vaickus, Z. Baloch (2016)
Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid CytopathologyCancer Cytopathology, 124
M. Hirokawa, J. Carney, J. Goellner, R. DeLellis, C. Heffess, R. Katoh,, M. Tsujimoto, K. Kakudo (2002)
Observer Variation of Encapsulated Follicular Lesions of the Thyroid GlandThe American Journal of Surgical Pathology, 26
F. Maletta, Federica Massa, L. Torregrossa, Eleonora Duregon, G. Casadei, F. Basolo, G. Tallini, M. Volante, Y. Nikiforov, M. Papotti (2016)
Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.Human pathology, 54
Z. Baloch, K. Shafique, Melina Flannagan, V. Livolsi (2010)
Encapsulated classic and follicular variants of papillary thyroid carcinoma: comparative clinicopathologic study.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 16 6
Objectives: The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) established diagnostic categories for cytologic specimens of the thyroid. Each category was associated with an estimated risk of malignancy. Recently, the non-invasive follicular variant of papillary thyroid carcinoma has been reclassified as benign. This reclassification may alter the malignancy risk of TBSRTC diagnostic categories. Study Design: A literature search was made for all studies investigating the effect of reclassification of some non-invasive follicular variant papillary thyroid carcinomas as benign on the malignancy risk associated with TBSRTC categories. The authors calculated the malignancy risk for TBSRTC categories in a series of 315 thyroid aspirates when the non-invasive follicular variant of papillary thyroid carcinoma was considered benign. A meta-analysis of malignancy risk data for the 3 published studies and the current study was performed. Results: The meta-analysis showed that the malignancy risk was reduced for all TBSRTC categories except the “non-diagnostic” category. The reduction in malignancy risk was greatest in the categories “suspicious for malignancy” and “atypia/follicular lesion of undetermined significance.” Conclusion: A meta-analysis of all pertinent studies demonstrated that re-categorization of the non-invasive follicular variant of papillary thyroid carcinoma as benign reduces the malignancy risk in the majority of TBSRTC categories.
Acta Cytologica – Karger
Published: Jan 1, 2017
Keywords: Malignancy risk; Meta-analysis; Bethesda System for Reporting Thyroid Cytopathology
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.